Coherus BioSciences (CHRS) Form 3 Initial statement of insider ownership

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

V-Sciences Investments Pte Ltd

(Last) (First) (Middle)

60B ORCHARD ROAD #06-18 TOWER 2

THE ATRIUM@ORCHARD

(Street)

SINGAPORE U0 238891

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/30/2019

3. Issuer Name and Ticker or Trading Symbol
Coherus BioSciences, Inc. [ CHRS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	7,381,116	D(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

V-Sciences Investments Pte Ltd

(Last) (First) (Middle)

60B ORCHARD ROAD #06-18 TOWER 2

THE ATRIUM@ORCHARD

(Street)

SINGAPORE U0 238891

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Temasek Life Sciences Private Ltd

(Last) (First) (Middle)

60B ORCHARD ROAD #06-18 TOWER 2

THE ATRIUM@ORCHARD

(Street)

SINGAPORE U0 238891

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Fullerton Management Pte Ltd

(Last) (First) (Middle)

60B ORCHARD ROAD #06-18 TOWER 2

THE ATRIUM@ORCHARD

(Street)

SINGAPORE U0 238891

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Temasek Holdings (Private) Ltd

(Last) (First) (Middle)

60B ORCHARD ROAD #06-18 TOWER 2

THE ATRIUM@ORCHARD

(Street)

SINGAPORE U0 238891

(City) (State) (Zip)

Explanation of Responses:

1. V-Sciences Investments Pte Ltd ("V-Sciences") directly owns 7,381,116 shares of Issuer's common stock. V-Sciences is a wholly-owned subsidiary of Temasek Life Sciences Private Limited ("Temasek Life Sciences"), which is a wholly-owned subsidiary of Fullerton Management Pte Ltd ("FMPL"), which is a wholly-owned subsidiary of Temasek Holdings (Private) Limited ("Temasek"). Each of Temasek Life Sciences, FMPL and Temasek, through the ownership described herein, may be deemed to beneficially own the shares held by V-Sciences.

Remarks:

	V-SCIENCES INVESTMENTS PTE LTD By: /s/ Zahedah Abdul Rashid, in her capacity as Director of V-Sciences Investments Pte Ltd	01/08/2020
	TEMASEK LIFE SCIENCES PRIVATE LIMITED By: /s/ Lim Siew Lee Sherlyn, in her capacity as Director of Temasek Life Sciences Private Limited	01/08/2020
	FULLERTON MANAGEMENT PTE LTD By: /s/ Cheong Kok Tim, in his capacity as Director of Fullerton Management Pte Ltd	01/08/2020
	TEMASEK HOLDINGS (PRIVATE) LIMITED By: /s/ Andrew Ang Lye Whatt, in his capacity as Authorized Signatory of Temasek Holdings (Private) Limited	01/08/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.